CytRx Corporation(CYTR)- NASDAQ
From other sites
Company Description
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It provides clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.
Sector: Healthcare
Industry: Biotechnology
Country: United States